Celularity Inc. . Full-time Email Format

Biotechnology ResearchNew Jersey, United States51-200 Employees

Celularity Inc. is a clinical-stage biotechnology company based in Florham Park, New Jersey, focused on advancing cellular medicine. It develops off-the-shelf allogeneic therapies derived from the postpartum placenta, including placenta-derived immune cells and pluripotent stem cells, with applications across cancer, infectious diseases, and degenerative conditions. The company emphasizes scalable, high-quality production and aims to make cell therapies more economically viable.

Positioning itself in the biotechnology research sector, Celularity develops therapies from placental material to address gaps in treatment for cancer, infectious diseases, and degenerative conditions. In 2025, the company launched Cenplacel-L, an investigational placenta-derived allogeneic cell therapy, which was made available for investigational use by licensed physicians in Florida under state statutes.

Sign up for free to view info

Company overview Employee directory